[PDF] Top 20 Estilos de vida en relación a la alimentación y hábitos alimentarios dentro y
Has 10000 "Estilos de vida en relación a la alimentación y hábitos alimentarios dentro y" found on our website. Below are the top 20 most common "Estilos de vida en relación a la alimentación y hábitos alimentarios dentro y".
HER2 breast cancer therapies: a review
... stage HER2 + breast cancer. Moreover, the HER2 receptor remains a viable target in spite of progres- sion and is a relevant target for novel anti-HER2 ...of HER2 therapy after ... See full document
192
A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections
... Breast cancer is the most common cause of cancer death in Europe and the second leading cause of cancer death in the United ...oncogene HER2, which encodes human epidermal growth factor ... See full document
7
Quantitative assays for the measurement of HER1 HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action
... Phosphorylated HER2 has been shown to be a predictor of poor response and survival in breast cancer patients in multiple studies ...FFPE breast cancer tissues, HER2-positive ... See full document
7
MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients
... HER2-overexpressing breast cancer represents approximately 20% of human breast cancers and is associated with an increased risk of tumor recurrence and reduced overall survival [1, ...of ... See full document
50
In vivo models in breast cancer research: progress, challenges and future directions
... A); HER2- positive; and triple-negative (ER/PR/HER2-negative) (Cardiff and Kenney, ...Tailored therapies have led to considerable success in treating some breast cancers, such as hormone ... See full document
41
Breast Cancer Therapies Present and Future
... and Her2/neu, and leads to the activation of AKT and mTOR, among other signaling pathways in a ...in breast cancer as well as other cancers ...of breast cancers are observed to have mutations, ... See full document
205
Cleavage of the extracellular domain of junctional adhesion molecule A is associated with resistance to anti HER2 therapies in breast cancer settings
... of HER2 expression has been shown to confer resistance to anti-HER2 therapies ...As HER2 and EGFR can activate Akt (although HER2 would be its dominant activator in breast ... See full document
17
Emerging therapies for breast cancer
... In breast cancer, some miRNAs have been shown to upregulate the functions of oncogenes while others stimulate tumor ...various breast cancer subtypes exhibit different molecular miRNA sig- ... See full document
10
Targeted therapies for breast cancer
... of breast cancer, together with the identification of the driving genetic alterations and signaling pathways, has led to the clinical development of a number of suc- cessful molecular targeted ...of ... See full document
8
CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models
... to HER2-targeted ...membrane HER2 or cytoplasmic signaling is associated with ...of HER2 positive models. The one exception encountered was a rare HER2-positive tumor that harbored loss of ... See full document
6
Clinical utility of serum HER2/neu in monitoring and prediction of progression free survival in metastatic breast cancer patients treated with trastuzumab based therapies
... that HER2/neu gene ampli- fication, measured using FISH, is the best predictive marker of response to trastuzumab-based therapy ...culating HER2/neu ECD as a predictive marker of response to such therapy ... See full document
10
The benefit of HER2 targeted therapies on overall survival of patients with metastatic HER2 positive breast cancer – a systematic review
... HER2-targeted therapies have an undeniable favorable impact in the outcome of patients with HER2+ meta- static ...OS. HER2 dual blockade with pertuzumab and trastuzumab is associated with a ... See full document
14
Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer
... metastatic HER2+ BC patients who had not received previous trastuzumab or chemotherapy for advanced BC within 12 months of ...Antonio Breast Cancer Symposium (SABCS) and published in Lancet ...the ... See full document
50
Targeted therapies for ER+/HER2- metastatic breast cancer
... positive breast cancer is the pan-PI3K inhibitor BKM120 (buparlisib) [46] (Table ...metastatic breast cancer pa- tients refractory to endocrine therapy ...advanced HER2-negative ... See full document
14
Activating Mutations in ERBB2 and Their Impact on Diagnostics and Treatment
... on cancer,” cancer remains one of the major causes of human morbidity and ...targeted therapies holds the most promise for the future, making identification of tumor-specific therapeutic targets of ... See full document
139
Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2 positive Breast Cancer Cells in Vitro
... the HER2 peptide and the HER2 ECD pro- tein, it is still unknown whether the aptamer would bind to the HER2-positive breast cancer ...the HER2-positive (SK-BR-3), or the ... See full document
14
Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer
... Patients alive at the last visit without documented evi- dence of distant metastases were censored. Associations between the pSTAT3-GS, pSTAT3, and clinical patho- logical parameters or other proteins were investigated ... See full document
6
Clinicopathological characteristics of patients with HER2-positive breast cancer and the efficacy of trastuzumab in the People’s Republic of China
... events: breast cancer recurrence at any site; metastasis; the development of ipsilat- eral or contralateral breast cancer, including ductal carcinoma in situ but not lobular carcinoma in situ; ... See full document
7
Polyclonal HER2 specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells
... [5,6]. HER2, in contrast to the other three receptors, is an orphan with no recognized endo- genous ligand; nevertheless, plasma membrane-localized HER2 signals as a consequence of intrinsic tyrosine kinase ... See full document
6
Critical analysis of the potential for targeting STAT3 in human malignancy
... in cancer, its role in promoting a wide variety of cancerous phenotypes, and the strong clinical and preclinical studies performed to date, STAT3 represents a promising target for the development of inhibi- tors ... See full document
8
Related subjects